__NUXT_JSONP__("/drugs/Tertomotide", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A synthetic peptide vaccine, containing 16 amino acid residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), with potential antineoplastic activity. Telomerase, a reverse transcriptase normally repressed in healthy cells, is overexpressed in most cancer cells and plays a key role in cellular proliferation. Vaccination with tertomotide may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against telomerase-expressing cells.",fdaUniiCode:"55R7RG342O",identifier:"C62756",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C1663","C1752"],synonyms:["GV 1001","GV-1001","GV1001","Human Telomerase Reverse Transcriptase (EC 2.7.7.49)-(611-626)-Peptide (Telomerase Catalytic Subunit Fragment)","PrimoVax","TERTOMOTIDE",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTertomotide",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Tertomotide","","2021-10-30T13:42:16.083Z")));